. . . . . . . "[Finally, the therapeutic response of BRAF(V600E) melanoma cells to vemurafenib requires downregulation of c-Myc and HIF-1? and upregulation of MondoA-TXNIP, and the subsequent reprogramming away from aerobic glycolysis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:13:18+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .